| Previous Close | 10.81 |
| Open | 10.72 |
| Bid | 10.37 x 100 |
| Ask | 11.40 x 500 |
| Day's Range | 10.38 - 11.74 |
| 52 Week Range | 5.90 - 25.17 |
| Volume | 4,795,993 |
| Avg. Volume | 2,052,625 |
| Market Cap | 323.34M |
| Beta | 1.92 |
| PE Ratio (TTM) | -4.80 |
| EPS (TTM) | -2.29 |
| Earnings Date | Oct 30, 2017 - Nov 3, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.40 |
- Motley Fool•3 days ago
3 Small-Cap Biotech Stocks to Buy This Fall
Why small-cap biotechs Celldex Therapeutics, Idera Pharmaceuticals, and NewLink Genetics could be big winners.
- Capital Cube•5 days ago
ETFs with exposure to NewLink Genetics Corp. : September 19, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NewLink Genetics Corp. Here are 5 ETFs with the largest exposure to NLNK-US. Comparing the performance and risk of NewLink Genetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Capital Cube•6 days agoNewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
Categories: Yahoo FinanceGet free summary analysis NewLink Genetics Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of NewLink Genetics Corp. – Eli Lilly and Company, Pfizer Inc., Sarepta Therapeutics, Inc., Johnson & Johnson and Bristol-Myers Squibb Company (LLY-US, PFE-US, SRPT-US, JNJ-US and BMY-US) that have ... Read more (Read more...)
